Redwood Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,858
Closed -$208K 314
2025
Q1
$208K Buy
+1,858
New +$192K 0.02% 283
2024
Q4
Sell
-24,855
Closed -$2.08M 346
2024
Q3
$2.08M Sell
24,855
-7,281
-23% -$556K 0.18% 110
2024
Q2
$2.21M Buy
32,136
+2,876
+10% +$192K 0.19% 105
2024
Q1
$2.14M Buy
29,260
+597
+2% +$45.9K 0.2% 126
2023
Q4
$2.32M Sell
28,663
-2,152
-7% -$167K 0.21% 103
2023
Q3
$2.31M Buy
+30,815
New +$2.37M 0.2% 95
2023
Q2
Sell
-24,436
Closed -$2.03M 247
2023
Q1
$2.03M Buy
24,436
+1,820
+8% +$151K 0.22% 91
2022
Q4
$1.94M Buy
+22,616
New +$1.79M 0.26% 91
2022
Q1
Sell
-22,399
Closed -$1.63M 300
2021
Q4
$1.63M Buy
22,399
+3,092
+16% +$213K 0.21% 124
2021
Q3
$1.35M Sell
19,307
-346
-2% -$24.3K 0.19% 122
2021
Q2
$1.35M Buy
19,653
+3,673
+23% +$245K 0.22% 105
2021
Q1
$1.03M Buy
15,980
+824
+5% +$53.1K 0.2% 121
2020
Q4
$883K Buy
15,156
+4,511
+42% +$272K 0.15% 143
2020
Q3
$673K Buy
10,645
+3,066
+40% +$213K 0.17% 182
2020
Q2
$583K Buy
+7,579
New +$581K 0.17% 177
2020
Q1
Sell
-5,949
Closed -$387K 188
2019
Q4
$387K Buy
5,949
+1,001
+20% +$65.2K 0.1% 221
2019
Q3
$314K Buy
4,948
+53
+1% +$3.46K 0.08% 222
2019
Q2
$331K Buy
4,895
+708
+17% +$46.6K 0.09% 199
2019
Q1
$272K Buy
+4,187
New +$278K 0.12% 127
2018
Q4
Sell
-3,735
Closed -$288K 76
2018
Q3
$288K Buy
3,735
+340
+10% +$25.7K 0.1% 101
2018
Q2
$241K Buy
3,395
+539
+19% +$38.1K 0.09% 95
2018
Q1
$215K Buy
+2,856
New +$227K 0.06% 112

Other funds holding GILD

Redwood Investment Management's GILD Position: Q2 2025 in Review

Redwood Investment Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 1,858 shares — an estimated $208K sold.

Redwood Investment Management first reported a position in GILD in Q1 2018 and held it in 22 quarters. The position peaked at $2.32M in Q4 2023. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Redwood Investment Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Redwood Investment Management sold 1,858 Gilead Sciences shares in Q2 2025, an estimated $208K.
  • Redwood Investment Management first reported a position in Gilead Sciences in Q1 2018 and held it in 22 quarters.
  • Redwood Investment Management's Gilead Sciences position peaked at $2.32M in Q4 2023.
  • 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Redwood Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.